Development and validation of a cephalosporin allergy clinical decision rule.

Saved in:
Bibliographic Details
Title: Development and validation of a cephalosporin allergy clinical decision rule.
Authors: Cox F; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia., Vogrin S; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia., Sullivan RP; Department of Infectious Diseases, St George Hospital, School of Clinical Medicine, UNSW Medicine and Health, Sydney, New South Wales, Australia., Stone C; Centre for Drug Safety and Immunology, Vanderbilt University Medical Centre, Nashville, TN, USA; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Centre, Nashville, TN, USA., Koo G; Centre for Drug Safety and Immunology, Vanderbilt University Medical Centre, Nashville, TN, USA; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Centre, Nashville, TN, USA., Phillips E; Centre for Drug Safety and Immunology, Vanderbilt University Medical Centre, Nashville, TN, USA; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Centre, Nashville, TN, USA., Li J; Department of Clinical Immunology and Allergy, Royal North Shore Hospital, Sydney, Australia; Immunology Laboratory, Royal North Shore Hospital, New South Wales Health Pathology, Sydney, Australia; Northern Clinical School, Faculty of Medicine and Health, Sydney University, Sydney, Australia., Fernando SL; Department of Clinical Immunology and Allergy, Royal North Shore Hospital, Sydney, Australia; Immunology Laboratory, Royal North Shore Hospital, New South Wales Health Pathology, Sydney, Australia; Northern Clinical School, Faculty of Medicine and Health, Sydney University, Sydney, Australia., Al Gassim M; Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Centre (MUHC), McGill University, Montreal, Quebec, Canada., Mitri E; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia; Department of Infectious Diseases, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., De Luca J; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia; Department of Infectious Diseases, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Rose M; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia; Department of Infectious Diseases, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Chua KYL; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia; Department of Infectious Diseases, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Holmes NE; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia; Department of Infectious Diseases, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Copaescu AM; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia; Immunology Laboratory, Royal North Shore Hospital, New South Wales Health Pathology, Sydney, Australia; Department of Infectious Diseases, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia; The Research Institute of the McGill University Health Centre, McGill University, McGill University Health Centre (MUHC), Montreal, Quebec, Canada., Trubiano JA; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia; Department of Infectious Diseases, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia. Electronic address: Jason.trubiano@austin.org.au.
Source: The Journal of infection [J Infect] 2025 Jun; Vol. 90 (6), pp. 106495. Date of Electronic Publication: 2025 Apr 25.
Publication Type: Journal Article; Validation Study
Journal Info: Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2742 (Electronic) Linking ISSN: 01634453 NLM ISO Abbreviation: J Infect Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-2742
DOI:10.1016/j.jinf.2025.106495